The only study that repeated aPL testing after one month included 31 patients with COVID-19 and found elevated aPL levels in 23 (74%) patients, of whom 21 (67%) had LA, 7 had aCL and aPS/PT, and 3 had anti-β2GPI [15]. The gene discussed is FASLG; the disease is COVID-19.